Protein kinase C and NF-κB-dependent CD4 downregulation in macrophages induced by T cell-derived soluble factors: Consequences for HIV-1 infection

Journal of Immunology

Volumn 187, Issue 2, 2011, Pages 748-759

  Raposo, Rui André Saraiva ^a,b   Trudgian, David C ^a   Thomas, Benjamin ^a   Van Wilgenburg, Bonnie ^a   Cowley, Sally A ^a   James, William ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF PORTO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ATTRACTIN; CD4 ANTIGEN; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; FIBRONECTIN; GALECTIN 3; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 13; INTERLEUKIN 16; INTERLEUKIN 5; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MACROPHAGE MIGRATION INHIBITION FACTOR; PROTEASOME; PROTEIN KINASE C; RANTES; SERINE; SERINE PROTEINASE INHIBITOR; TRANSPORTER ASSOCIATED WITH ANTIGEN PROCESSING 1; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN EXPRESSION; ARTICLE; CD4+ T LYMPHOCYTE; CELL ADHESION; CELL SPREADING; CONTROLLED STUDY; CYTOKINE RELEASE; DOWN REGULATION; ENZYME ACTIVITY; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MACROPHAGE; POLARIZATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; SUPERNATANT; T LYMPHOCYTE ACTIVATION; TANDEM MASS SPECTROMETRY; TH1 CELL; TH2 CELL; VIRUS ENTRY; VIRUS REPLICATION;

ADULT; ANTIGENS, CD4; CELL DIFFERENTIATION; CELLS, CULTURED; CYTOKINES; DOWN-REGULATION; HIV INFECTIONS; HIV-1; HUMANS; LYMPHOCYTE ACTIVATION; MACROPHAGES; NF-KAPPA B; PROTEIN KINASE C; SOLUBILITY; T-LYMPHOCYTES; VIRUS REPLICATION;

EID: 79960510967     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1003678     Document Type: Article

References (75)

1. Collman, R., B. Godfrey, J. Cutilli, A. Rhodes, N. F. Hassan, R. Sweet, S. D. Douglas, H. Friedman, N. Nathanson, and F. Gonzalez-Scarano. 1990. Macrophage-tropic strains of human immunodeficiency virus type 1 utilize the CD4 receptor. J. Virol. 64: 4468-4476. (Pubitemid 20279860)
2. Lynch, G. W., S. Turville, B. Carter, A. J. Sloane, A. Chan, N. Muljadi, S. Li, L. Low, P. Armati, R. Raison, et al. 2006. Marked differences in the structures and protein associations of lymphocyte and monocyte CD4: resolution of a novel CD4 isoform. Immunol. Cell Biol. 84: 154-165.
3. Li, Y., L. Li, R. Wadley, S. W. Reddel, J. C. Qi, C. Archis, A. Collins, E. Clark, M. Cooley, S. Kouts, et al. 2001. Mast cells/basophils in the peripheral blood of allergic individuals who are HIV-1 susceptible due to their surface expression of CD4 and the chemokine receptors CCR3, CCR5, and CXCR4. Blood 97: 3484-3490.
4. Basch, R. S., Y. H. Kouri, and S. Karpatkin. 1990. Expression of CD4 by human megakaryocytes. Proc. Natl. Acad. Sci. USA 87: 8085-8089.
5. Trobridge, P. A., K. A. Forbush, and S. D. Levin. 2001. Positive and negative selection of thymocytes depends on Lck interaction with the CD4 and CD8 coreceptors. J. Immunol. 166: 809-818.
6. Doyle, C., and J. L. Strominger. 1987. Interaction between CD4 and class II MHC molecules mediates cell adhesion. Nature 330: 256-259.
7. Graziani-Bowering, G. M., L. G. Filion, P. Thibault, and M. Kozlowski. 2002. CD4 is active as a signaling molecule on the human monocytic cell line Thp-1. Exp. Cell Res. 279: 141-152.
8. Cole, J. A., S. A. McCarthy, M. A. Rees, S. O. Sharrow, and A. Singer. 1989. Cell surface comodulation of CD4 and T cell receptor by anti-CD4 monoclonal antibody. J. Immunol. 143: 397-402. (Pubitemid 19191528)
9. Karsten, V., S. Gordon, A. Kirn, and G. Herbein. 1996. HIV-1 envelope glycoprotein gp120 down-regulates CD4 expression in primary human macrophages through induction of endogenous tumour necrosis factor-α. Immunology 88: 55-60. (Pubitemid 26166376)
10. Garofalo, T., M. Sorice, R. Misasi, B. Cinque, M. Giammatteo, G. M. Pontieri, M. G. Cifone, and A. Pavan. 1998. A novel mechanism of CD4 down-modulation induced by monosialoganglioside GM3: involvement of serine phosphorylation and protein kinase Cδ translocation. J. Biol. Chem. 273: 35153-35160.
11. Pitcher, C., S. Höning, A. Fingerhut, K. Bowers, and M. Marsh. 1999. Cluster of differentiation antigen 4 (CD4) endocytosis and adaptor complex binding require activation of the CD4 endocytosis signal by serine phosphorylation. Mol. Biol. Cell 10: 677-691.
12. Golding, H., D. S. Dimitrov, J. Manischewitz, C. C. Broder, J. Robinson, S. Fabian, D. R. Littman, and C. K. Lapham. 1995. Phorbol ester-induced down modulation of tailless CD4 receptors requires prior binding of gp120 and suggests a role for accessory molecules. J. Virol. 69: 6140-6148.
13. Pelchen-Matthews, A., I. J. Parsons, and M. Marsh. 1993. Phorbol ester-induced downregulation of CD4 is a multistep process involving dissociation from p56lck, increased association with clathrin-coated pits, and altered endosomal sorting. J. Exp. Med. 178: 1209-1222.
14. Hoxie, J. A., J. L. Rackowski, B. S. Haggarty, and G. N. Gaulton. 1988. T4 endocytosis and phosphorylation induced by phorbol esters but not by mitogen or HIV infection. J. Immunol. 140: 786-795.
15. Acres, R. B., P. J. Conlon, D. Y. Mochizuki, and B. Gallis. 1986. Rapid phosphorylation and modulation of the T4 antigen on cloned helper T cells induced by phorbol myristate acetate or antigen. J. Biol. Chem. 261: 16210-16214.
16. Pelchen-Matthews, A., R. P. da Silva, M. J. Bijlmakers, N. Signoret, S. Gordon, and M. Marsh. 1998. Lack of p56lck expression correlates with CD4 endocytosis in primary lymphoid and myeloid cells. Eur. J. Immunol. 28: 3639-3647.
17. Pelchen-Matthews, A., J. E. Armes, G. Griffiths, and M. Marsh. 1991. Differential endocytosis of CD4 in lymphocytic and nonlymphocytic cells. J. Exp. Med. 173: 575-587.
18. + cell anti-HIV factor (CAF). Trends Immunol. 24: 628-632.
19. + T cells suppress human immunodeficiency virus replication by inhibiting viral transcription. Proc. Natl. Acad. Sci. USA 92: 2308-2312.
20. + cell noncytotoxic anti-human immunodeficiency virus response inhibits expression of viral RNA but not reverse transcription or provirus integration. J. Gen. Virol. 81: 1261-1264.
21. Verani, A., F. Sironi, A. G. Siccardi, P. Lusso, and D. Vercelli. 2002. Inhibition of CXCR4-tropic HIV-1 infection by lipopolysaccharide: evidence of different mechanisms in macrophages and T lymphocytes. J. Immunol. 168: 6388-6395. (Pubitemid 34620063)
22. Mikulak, J., M. Gianolini, P. Versmisse, G. Pancino, P. Lusso, and A. Verani. 2009. Biological and physical characterization of the X4 HIV-1 suppressive factor secreted by LPS-stimulated human macrophages. Virology 390: 37-44.
23. Zolla-Pazner, S., and S. Sharpe. 1995. A resting cell assay for improved detection of antibody-mediated neutralization of HIV type 1 primary isolates. AIDS Res. Hum. Retroviruses 11: 1449-1458.
24. Porcheray, F., B. Samah, C. Léone, N. Dereuddre-Bosquet, and G. Gras. 2006. Macrophage activation and human immunodeficiency virus infection: HIV replication directs macrophages towards a pro-inflammatory phenotype while previous activation modulates macrophage susceptibility to infection and viral production. Virology 349: 112-120. (Pubitemid 43732479)
25. Gartner, S., P. Markovits, D. M. Markovitz, R. F. Betts, and M. Popovic. 1986. Virus isolation from and identification of HTLV-III/LAV - producing cells in brain tissue from a patient with AIDS. JAMA 256: 2365-2371. (Pubitemid 17174464)
26. Butler, S. L., M. S. Hansen, and F. D. Bushman. 2001. A quantitative assay for HIV DNA integration in vivo. Nat. Med. 7: 631-634.
27. Cohen, C., M. Forzan, B. Sproat, R. Pantophlet, I. McGowan, D. Burton, and W. James. 2008. An aptamer that neutralizes R5 strains of HIV-1 binds to core residues of gp120 in the CCR5 binding site. Virology 381: 46-54.
28. Carter, G. C., L. Bernstone, D. Sangani, J. W. Bee, T. Harder, and W. James. 2009. HIV entry in macrophages is dependent on intact lipid rafts. Virology 386: 192-202.
29. Herbein, G., P. Illei, L. J. Montaner, W. James, and S. Gordon. 1996. Comparison of p24 measurement by ELISA versus indicator cells for detecting residual HIV infectivity in vitro. J. Virol. Methods 58: 167-173. (Pubitemid 26000599)
30. Hermann, E., E. Darcissac, T. Idziorek, A. Capron, and G. M. Bahr. 1999. Recombinant interleukin-16 selectively modulates surface receptor expression and cytokine release in macrophages and dendritic cells. Immunology 97: 241-248.
31. ΔΔC(T) Method. Methods 25: 402-408.
32. Cox, J., I. Matic, M. Hilger, N. Nagaraj, M. Selbach, J. V. Olsen, and M. Mann. 2009. A practical guide to the MaxQuant computational platform for SILAC-based quantitative proteomics. Nat. Protoc. 4: 698-705.
33. Cox, J., and M. Mann. 2008. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat. Biotechnol. 26: 1367-1372.
34. Griffin, N. M., J. Yu, F. Long, P. Oh, S. Shore, Y. Li, J. A. Koziol, and J. E. Schnitzer. 2010. Label-free, normalized quantification of complex mass spectrometry data for proteomic analysis. Nat. Biotechnol. 28: 83-89.
35. Trudgian, D. C., B. Thomas, S. J. McGowan, B. M. Kessler, M. Salek, and O. Acuto. 2010. CPFP: a central proteomics facilities pipeline. Bioinformatics 26: 1131-1132.
36. von Bernuth, H., C. L. Ku, C. Rodriguez-Gallego, S. Zhang, B. Z. Garty, L. Maródi, H. Chapel, M. Chrabieh, R. L. Miller, C. Picard, et al. 2006. A fast procedure for the detection of defects in Toll-like receptor signaling. Pediatrics 118: 2498-2503. (Pubitemid 46397591)
37. Brooks, P., R. Z. Murray, G. G. Mason, K. B. Hendil, and A. J. Rivett. 2000. Association of immunoproteasomes with the endoplasmic reticulum. Biochem. J. 352: 611-615.
38. Wang, H. X., H. M. Wang, H. Y. Lin, Q. Yang, H. Zhang, B. K. Tsang, and C. Zhu. 2006. Proteasome subunit LMP2 is required for matrix metalloproteinase-2 and -9 expression and activities in human invasive extravillous trophoblast cell line. J. Cell. Physiol. 206: 616-623.
39. Wright, K. L., L. C. White, A. Kelly, S. Beck, J. Trowsdale, and J. P. Ting. 1995. Coordinate regulation of the human TAP1 and LMP2 genes from a shared bidirectional promoter. J. Exp. Med. 181: 1459-1471.
40. Mori, N., Y. Yamada, S. Ikeda, Y. Yamasaki, K. Tsukasaki, Y. Tanaka, M. Tomonaga, N. Yamamoto, and M. Fujii. 2002. Bay 11-7082 inhibits transcription factor NF-κB and induces apoptosis of HTLV-I - infected T-cell lines and primary adult T-cell leukemia cells. Blood 100: 1828-1834. (Pubitemid 34925163)
41. Fields, A. P., D. P. Bednarik, A. Hess, and W. S. May. 1988. Human immunodeficiency virus induces phosphorylation of its cell surface receptor. Nature 333: 278-280.
42. Kazazi, F., J.-M. Mathijs, P. Foley, and A. L. Cunningham. 1989. Variations in CD4 expression by human monocytes and macrophages and their relationships to infection with the human immunodeficiency virus. J. Gen. Virol. 70: 2661-2672.
43. Shin, J., R. L. Dunbrack, Jr., S. Lee, and J. L. Strominger. 1991. Phosphorylation-dependent down-modulation of CD4 requires a specific structure within the cytoplasmic domain of CD4. J. Biol. Chem. 266: 10658-10665.
44. Shin, J., C. Doyle, Z. Yang, D. Kappes, and J. L. Strominger. 1990. Structural features of the cytoplasmic region of CD4 required for internalization. EMBO J. 9: 425-434.
45. Qatsha, K. A., C. Rudolph, D. Marmé, C. Schächtele, and W. S. May. 1993. Gö6976, a selective inhibitor of protein kinase C, is a potent antagonist of human immunodeficiency virus 1 induction from latent/low-level - producing reservoir cells in vitro. Proc. Natl. Acad. Sci. USA 90: 4674-4678.
46. Martiny-Baron, G., M. G. Kazanietz, H. Mischak, P. M. Blumberg, G. Kochs, H. Hug, D. Marmé, and C. Schächtele. 1993. Selective inhibition of protein kinase C isozymes by the indolocarbazole Gö 6976. J. Biol. Chem. 268: 9194-9197.
47. Cassol, E., L. Cassetta, C. Rizzi, M. Alfano, and G. Poli. 2009. M1 and M2a polarization of human monocyte-derived macrophages inhibits HIV-1 replication by distinct mechanisms. J. Immunol. 182: 6237-6246.
48. Righetti, P. G., and E. Boschetti. 2008. The ProteoMiner and the FortyNiners: searching for gold nuggets in the proteomic arena. Mass Spectrom. Rev. 27: 596-608.
49. Boschetti, E., and P. G. Righetti. 2008. The ProteoMiner in the proteomic arena: a non-depleting tool for discovering low-abundance species. J. Proteomics 71: 255-264.
50. Wang, Z. M., X. Li, R. R. Cocklin, M. Wang, M. Wang, K. Fukase, S. Inamura, S. Kusumoto, D. Gupta, and R. Dziarski. 2003. Human peptidoglycan recognition protein-L is an N-acetylmuramoyl-L-alanine amidase. J. Biol. Chem. 278: 49044-49052.
51. Twal, W. O., A. Czirok, B. Hegedus, C. Knaak, M. R. Chintalapudi, H. Okagawa, Y. Sugi, and W. S. Argraves. 2001. Fibulin-1 suppression of fibronectin-regulated cell adhesion and motility. J. Cell Sci. 114: 4587-4598.
52. Duke-Cohan, J. S., W. Tang, and S. F. Schlossman. 2000. Attractin: a cub-family protease involved in T cell-monocyte/macrophage interactions. Adv. Exp. Med. Biol. 477: 173-185.
53. Tang, W., T. M. Gunn, D. F. McLaughlin, G. S. Barsh, S. F. Schlossman, and J. S. Duke-Cohan. 2000. Secreted and membrane attractin result from alternative splicing of the human ATRN gene. Proc. Natl. Acad. Sci. USA 97: 6025-6030.
54. Duke-Cohan, J. S., J. Gu, D. F. McLaughlin, Y. Xu, G. J. Freeman, and S. F. Schlossman. 1998. Attractin (DPPT-L), a member of the CUB family of cell adhesion and guidance proteins, is secreted by activated human T lymphocytes and modulates immune cell interactions. Proc. Natl. Acad. Sci. USA 95: 11336-11341.
55. Sasaki, T., C. Brakebusch, J. Engel, and R. Timpl. 1998. Mac-2 binding protein is a cell-adhesive protein of the extracellular matrix which self-assembles into ring-like structures and binds b1 integrins, collagens and fibronectin. EMBO J. 17: 1606-1613. (Pubitemid 28119114)
56. Ullrich, A., I. Sures, M. D'Egidio, B. Jallal, T. J. Powell, R. Herbst, A. Dreps, M. Azam, M. Rubinstein, C. Natoli, et al. 1994. The secreted tumor-associated antigen 90K is a potent immune stimulator. J. Biol. Chem. 269: 18401-18407.
57. Godfrey, H. P. 1990. T cell fibronectin: an unexpected inflammatory lymphokine. Lymphokine Res. 9: 435-447. (Pubitemid 20240115)
58. Raposo, R. A. S., B. Thomas, G. Ridlova, and W. James. 2011. Proteomic-based identification of CD4-interacting proteins in human primary macrophages. PLoS One 6: e18690.
59. Petersen, C. M., E. I. Christensen, B. S. Andresen, and B. K. Møller. 1992. Internalization, lysosomal degradation and new synthesis of surface membrane CD4 in phorbol ester-activated T-lymphocytes and U-937 cells. Exp. Cell Res. 201: 160-173.
60. Tan, S. L., and P. J. Parker. 2003. Emerging and diverse roles of protein kinase C in immune cell signalling. Biochem. J. 376: 545-552.
61. Genot, E. M., P. J. Parker, and D. A. Cantrell. 1995. Analysis of the role of protein kinase C-α, -ε, and -ζ in T cell activation. J. Biol. Chem. 270: 9833-9839.
62. Spitaler, M., and D. A. Cantrell. 2004. Protein kinase C and beyond. Nat. Immunol. 5: 785-790.
63. Saijo, K., I. Mecklenbräuker, A. Santana, M. Leitger, C. Schmedt, and A. Tarakhovsky. 2002. Protein kinase Cβ controls nuclear factor κB activation in B cells through selective regulation of the IkB kinase a. J. Exp. Med. 195: 1647-1652.
64. 2+-dependent signal transduction pathways. J. Immunol. 155: 4685-4691.
65. + T-cell antiviral factor. J. Biol. Chem. 277: 42352-42357.
66. Duke-Cohan, J. S., C. Morimoto, J. A. Rocker, and S. F. Schlossman. 1996. Serum high molecular weight dipeptidyl peptidase IV (CD26) is similar to a novel antigen DPPT-L released from activated T cells. J. Immunol. 156: 1714-1721.
67. Matarese, G., and A. La Cava. 2004. The intricate interface between immune system and metabolism. Trends Immunol. 25: 193-200. (Pubitemid 38368167)
68. Blum, S., F. Hug, G. M. Hänsch, and C. Wagner. 2005. Fibronectin on activated T lymphocytes is bound to gangliosides and is present in detergent insoluble microdomains. Immunol. Cell Biol. 83: 167-174.
69. Donson, J., K. Mandy, Z. H. Feng, S. Mandy, E. J. Brown, and H. P. Godfrey. 1991. Role of monocyte fucose-receptors in T-cell fibronectin activity. Immunology 74: 473-477.
70. Godfrey, H. P., L. S. Canfield, C. V. Angadi, L. M. Zagachin, G. G. Kielpinski, and R. B. Colvin. 1990. Characterization of lymphokine fibronectin from guinea pig lymphoid cell culture supernatants. Immunobiology 180: 109-123.
71. Liu, Y., and W. J. Kao. 2002. Human macrophage adhesion on fibronectin: the role of substratum and intracellular signalling kinases. Cell. Signal. 14: 145-152.
72. Defilippi, P., M. Venturino, D. Gulino, A. Duperray, P. Boquet, C. Fiorentini, G. Volpe, M. Palmieri, L. Silengo, and G. Tarone. 1997. Dissection of pathways implicated in integrin-mediated actin cytoskeleton assembly. Involvement of protein kinase C, Rho GTPase, and tyrosine phosphorylation. J. Biol. Chem. 272: 21726-21734.
73. Huang, X., J. Wu, S. Spong, and D. Sheppard. 1998. The integrin avb6 is critical for keratinocyte migration on both its known ligand, fibronectin, and on vitronectin. J. Cell Sci. 111: 2189-2195. (Pubitemid 28403697)
74. vβ5-dependent cytoskeletal associations and focal adhesion kinase phosphorylation. J. Cell Biol. 134: 1323-1332.
75. Liao, L., and S. Jaken. 1993. Effect of a-protein kinase C neutralizing antibodies and the pseudosubstrate peptide on phosphorylation, migration, and growth of REF52 cells. Cell Growth Differ. 4: 309-316.